Viemed Healthcare Q1 2024 GAAP EPS $0.04 Misses $0.07 Estimate, Sales $50.593M Beat $50.000M Estimate
Viemed Healthcare Q1 2024 GAAP EPS $0.04 Misses $0.07 Estimate, Sales $50.593M Beat $50.000M Estimate
Viemed Healthcare 2024年第一季度GAAP每股收益0.04美元未達到0.07美元的預期，5,0593萬美元的銷售額超過5000萬美元的預期
Viemed Healthcare (NASDAQ:VMD) reported quarterly earnings of $0.04 per share which missed the analyst consensus estimate of $0.07 by 42.86 percent. This is unchanged from the same period last year. The company reported quarterly sales of $50.593 million which beat the analyst consensus estimate of $50.000 million by 1.19 percent. This is a 27.90 percent increase over sales of $39.556 million the same period last year.
Viemed Healthcare（納斯達克股票代碼：VMD）公佈的季度收益爲每股0.04美元，比分析師普遍預期的0.07美元低42.86％。這與去年同期相比沒有變化。該公司公佈的季度銷售額爲5,0593萬美元，比分析師普遍預期的5000萬美元高出1.19％。這比去年同期的3,955.6萬美元的銷售額增長了27.90％。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。